Q&A: Scientists cautiously optimistic about trial results of new preventative HIV treatment
Researchers may have found a powerful new preventative against the AIDS virus, which has killed more than 40 million people since the epidemic began in 1981.
Jul 25, 2024
0
0
Proof-of-concept study finds HIV-like virus particle could end need for need for lifelong medications
Researchers in George Mason University's Center for Infectious Disease Research (CIDR) and Tulane National Primate Research Center have conducted a breakthrough proof-of-concept study, published in the journal Gene Therapy, ...
Jul 24, 2024
0
19
Experts say a twice-yearly injection that offers 100% protection against HIV is 'stunning'
Twice-yearly shots used to treat AIDS were 100% effective in preventing new infections in women, according to study results published Wednesday.
Jul 24, 2024
1
5
New study determines incidence of and risk factors for hepatitis C virus reinfection among men with HIV
This study provides new perspectives on transmission of hepatitis C virus (HCV), a virus that infects the liver and can be transmitted during injection of drugs, among men who have sex with men (MSM).
Jul 24, 2024
0
0
Behavioral pain self-management intervention effective for chronic pain with HIV
A behavioral pain self-management intervention is effective for chronic pain in people living with HIV, according to a study published online July 15 in JAMA Internal Medicine.
Jul 24, 2024
0
0
New 'vaccine-like' HIV drug could cost just $40: Researchers
A new "vaccine-like" HIV drug that currently costs over $40,000 per person a year could be made for as little as $40, researchers estimated on Tuesday.
Jul 23, 2024
0
54
Long-acting injectable cabotegravir for HIV prevention found safe in pregnancy
Long-acting injectable cabotegravir (CAB-LA) was safe and well-tolerated as HIV pre-exposure prophylaxis (PrEP) before and during pregnancy in the follow-up phase of a global study among cisgender women. The analysis of outcomes ...
Jul 23, 2024
0
0
An isolated viral load test may generate false positive results for people using long-acting PrEP
A single laboratory-based HIV viral load test used by U.S. clinicians who provide people with long-acting, injectable cabotegravir (CAB-LA) HIV pre-exposure prophylaxis (PrEP) did not reliably detect HIV in a multi-country ...
Jul 23, 2024
0
0
UN says nearly 40 million people had HIV in 2023, lack of treatment means someone died every minute
Nearly 40 million people were living with the HIV virus that causes AIDS last year, over 9 million weren't getting any treatment, and the result was that every minute someone died of AIDS-related causes, the U.N. said in ...
Jul 23, 2024
0
0
Exploratory analysis associates HIV drug abacavir with elevated cardiovascular disease risk in large global trial
Current or previous use of the antiretroviral drug (ARV) abacavir was associated with an elevated risk of major adverse cardiovascular events (MACE) in people with HIV, according to an exploratory analysis from a large international ...
Jul 23, 2024
0
0
UN urges Gilead to 'make history' with game-changing HIV drug
Gilead could bring the AIDS pandemic towards an end if the US pharmaceutical giant opens up access to its game-changing new HIV drug, the head of UNAIDS told AFP.
Jul 22, 2024
0
0
UN says 2024 decisive to ending AIDS as health threat
Decisions political leaders take this year will be decisive whether a target to end AIDS as a public health threat by 2030 can be reached, the United Nations said Monday.
Jul 22, 2024
0
0
Seventh person likely 'cured' of HIV, doctors announce
A 60-year-old German man is likely the seventh person to be effectively cured from HIV after receiving a stem cell transplant, doctors announced on Thursday.
Jul 18, 2024
0
1
Improving HIV treatment in children and adolescents, the right way
Globally, around 2.6 million children and adolescents are currently living with HIV, the majority of them in Africa. These young people are much more likely to experience treatment failure than adults. Experts long assumed ...
Jul 17, 2024
0
0
Llama nanobodies: New therapy can neutralize a wide variety of HIV-1 strains
A research team at Georgia State University has developed tiny, potent molecules that are capable of targeting hidden strains of HIV. The source? Antibody genes from llama DNA.
Jul 17, 2024
0
41
The impact of tobacco smoking and smoking cessation on the life expectancy of people with HIV in South Africa
Now that more people with HIV in South Africa are on antiretroviral therapy (medicines to treat HIV), more are surviving long enough to face the health consequences of tobacco smoking.
Jul 16, 2024
0
0
Self-management program found to help patients with HIV and chronic pain
An intensive, 12-week pain self-management program has been shown to reduce pain and improve mood in a large clinical trial of people with both HIV and chronic pain. The research, led by University of Pittsburgh physician-scientist ...
Jul 15, 2024
0
0
Tennessee's shift in HIV prevention funding will lead to poorer health outcomes for its residents, suggests study
A study published in Clinical Infectious Diseases led by Massachusetts General Hospital investigators, warns that Tennessee's new HIV prevention funding policy will lead to poorer health outcomes for its residents.
Jul 15, 2024
0
0
